Growth funding XAnge is a €800 million early-stage fund actively investing across Seed to Series C in Europe, presenting a target opportunity to offer portfolio support services, co-investment leads, and scalable fund-of-funds introductions to potential LPs or co-investors.

Deep tech focus With bets in deep tech, AI, energy transition, and healthcare (examples include Tomorro, Diagnoly, Homaio Carbon), there is a clear need for technical due diligence, specialized tooling, and technical advisory services that align with XAnge's investment criteria.

European footprint Offices in Paris, Berlin, and Brussels combined with a diverse European portfolio create opportunities to tailor region-specific partnerships, market entry support, and go-to-market collaborations for portfolio founders expanding across Europe.

Active exits and rounds Recent sizable rounds and exits across AI, SaaS, and deep tech indicate appetite for continued capital deployment; sales teams can target XAnge as a strategic partner for follow-on rounds, co-investment, and advisory roles in scaling portfolio companies.

Portfolio synergies A broad mix of investments from cybersecurity to contract management and ultrasound AI suggests potential for cross-portfolio partnerships, shared technology due diligence, and bundled services or platforms that could streamline fundraising and product development for multiple portfolio companies.